That really is a sad state of affair, insulin is cheap to produce and we shouldn't live in a world where such a basic medicine is controlled by for profit organizations.
At least in countries with a proper health system the cost isn't impacting on an individual level.
https://beyondtype1.org/how-much-does-it-cost-to-produce-ins...
Ended up switching back to generic novolin R (regular) as injections which allows me to use different areas of the body, eat low carb, and dropped my a1c down 3 points. Reduced my standard deviation of blood sugars by about 45 as well.
Every diabetic is different though as others have found great success with novolog, insulin pumps, etc.
What I’ve heard from other diabetics is that the older Novolin drugs take a lot more effort to get constant insulin levels than the newer ones.
I guess not true for everyone!!
Is there any reason this wouldn't be subject to the normal laws of supply and demand?
Looks like a patent issue (every new improvement in production methods has its own patent, so the insulins for which patents have expired are lower-quality in one way or another) plus shipping costs (refrigerated bottled liquids with a shelf life <6 months).
The price of insulin is already rising: there aren't all that many generic manufacturers of it, leaving them in a competition-free market. If this takes off it's going to suck up a good chunk of the marketplace, and probably leave us with maybe one or two generic manufacturers - enough to have an effective monopoly. Insulin prices will spike the same way epi pens did.
Good tech. But sad re. what it's going to do to patients for a while.